1. Home
  2. ATI vs ARWR Comparison

ATI vs ARWR Comparison

Compare ATI & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ATI Inc.

ATI

ATI Inc.

HOLD

Current Price

$122.45

Market Cap

11.2B

Sector

Industrials

ML Signal

HOLD

Logo Arrowhead Pharmaceuticals Inc.

ARWR

Arrowhead Pharmaceuticals Inc.

HOLD

Current Price

$64.51

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATI
ARWR
Founded
1960
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.2B
9.6B
IPO Year
N/A
1993

Fundamental Metrics

Financial Performance
Metric
ATI
ARWR
Price
$122.45
$64.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
10
Target Price
$111.57
$72.70
AVG Volume (30 Days)
1.5M
2.8M
Earning Date
02-03-2026
02-09-2026
Dividend Yield
N/A
N/A
EPS Growth
18.88
N/A
EPS
3.10
N/A
Revenue
$4,583,000,000.00
$829,448,000.00
Revenue This Year
$6.39
N/A
Revenue Next Year
$8.30
N/A
P/E Ratio
$38.23
N/A
Revenue Growth
7.75
23258.15
52 Week Low
$39.23
$9.57
52 Week High
$123.96
$76.76

Technical Indicators

Market Signals
Indicator
ATI
ARWR
Relative Strength Index (RSI) 74.42 52.00
Support Level $115.80 $63.00
Resistance Level $122.57 $69.42
Average True Range (ATR) 3.27 3.58
MACD 0.08 -1.34
Stochastic Oscillator 82.43 26.64

Price Performance

Historical Comparison
ATI
ARWR

About ATI ATI Inc.

ATI Inc supplies specialty metals to various end markets, including aerospace and defense, oil and gas, automotive, and electrical energy, among many others. The company's operating segment includes High-Performance Materials and Components and Advanced Alloys and Solutions. The majority of revenue is from the High-Performance Materials segment. The High-Performance Materials segment is focused on a wide range of high-performance specialty materials, parts, and components for several the majority of end markets, including the aerospace & defense, medical, and energy markets. Geographically, it operates in the United States, China, the United Kingdom, Germany, France, Canada, and Others, the majority is from the United States.

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

Share on Social Networks: